Lymphomas
A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrutinib (BGB-3111-215)
- Details
ClinicalTrials.gov ID:
NCT03206918
Diagnosis Type:
NA
USOR Number:
- Address
1800 N Williams St, Suite 200
Denver, CO 80218
P: (303) 388-4876